What is Harmony Biosciences Holdings?
, a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.91B, and a P/E ratio of 10.8x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 772,406 shares $3.1M | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 570,640 shares $2.7M | 0 |